Compare DMII & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DMII | CRMD |
|---|---|---|
| Founded | 2024 | 2006 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 641.5M | 695.9M |
| IPO Year | N/A | 2009 |
| Metric | DMII | CRMD |
|---|---|---|
| Price | $10.14 | $7.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 64.0K | ★ 920.7K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.79 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $9.87 | $6.13 |
| 52 Week High | $10.20 | $14.96 |
| Indicator | DMII | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 64.70 | 34.10 |
| Support Level | $10.06 | $7.05 |
| Resistance Level | N/A | $7.44 |
| Average True Range (ATR) | 0.02 | 0.38 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 42.86 | 5.66 |
Drugs Made In America Acquisition II Corp is a blank check Company.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.